Imvanex

BIOLOGICAL2 trials

Sponsors

Academisch Ziekenhuis Leiden, Janssen Research & Development, LLC

Conditions

Healthympox (earlier: monkey pox)

Early Phase 1

A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants

CompletedNCT03953196

Janssen Research & Development, LLCHealthy

Start: 2019-04-08End: 2019-12-26Updated: 2025-02-03

Phase 2

Immunogenicity and safety of a fractional subcutaneous booster booster vaccination against mpox with MVA-BN: a randomised-controlled non-inferiority study (SUBO-trial)

RecruitingCTIS2024-510697-24-00

Academisch Ziekenhuis Leidenmpox (earlier: monkey pox)

Start: 2025-01-02Target: 220Updated: 2025-04-24

Related Papers

Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.

2024-08-308 citations